Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec 12;12(12):CD005053.
doi: 10.1002/14651858.CD005053.pub4.

Adjuvant antiviral therapy for recurrent respiratory papillomatosis

Neil K Chadha  1 , Adrian James
Affiliations

Adjuvant antiviral therapy for recurrent respiratory papillomatosis

Neil K Chadha et al. Cochrane Database Syst Rev. .

Abstract

Background: This is an update of a Cochrane Review originally published in Issue 4, 2005 of The Cochrane Library and previously updated in 2010.Recurrent respiratory papillomatosis is a condition characterised by benign papillomatous (wart-like) growths in the upper airway. It can affect both adults and children causing airway obstruction and voice change. Treatment usually involves repeated surgical debulking of the papillomata. Several agents have been proposed as adjuvants to surgical debulking, including antivirals, administered systemically or injected into the lesions.

Objectives: To assess the effectiveness of antiviral agents as adjuvant therapy in the management of recurrent respiratory papillomatosis in children and adults.

Search methods: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials (CENTRAL); PubMed; EMBASE; CINAHL; Web of Science; BIOSIS Previews; Cambridge Scientific Abstracts; ICTRP and additional sources for published and unpublished trials. The date of the most recent search was 24 February 2012.

Selection criteria: Randomised controlled trials.

Data collection and analysis: We identified 143 references from the searches. Forty-three were appropriate for retrieval and assessed for eligibility by the authors. One randomised controlled trial met the inclusion criteria, involving 19 participants. We contacted the authors to obtain additional data to facilitate the review.

Main results: The included study was a single-institution, randomised, double-blind, placebo-controlled trial of intralesional cidofovir administered at the time of surgical debulking. Adults (n = 15) and children (n = 4) were included. We judged the study to have a reasonably low risk of bias. After a 12-month trial period, no difference was found between the cidofovir and placebo groups. Both groups showed a significant reduction in disease extent (as assessed at the time of surgery using the Derkay Scoring System), but no significant change in health-related quality of life.

Authors' conclusions: There is insufficient evidence to support the efficacy of antiviral agents as adjuvant therapy in the management of recurrent respiratory papillomatosis in children or adults. The included randomised controlled trial showed no advantage of intralesional cidofovir over placebo at 12 months. The study was limited by a small sample size and a change in the cidofovir concentration midway through the trial, from 0.3 mg/ml in children and 0.75 mg/ml in adults, to 5 mg/ml in both adults and children. An adequately powered randomised controlled trial of intra-lesional cidofovir, consistently using higher concentrations of cidofovir in comparison with injected placebo, would be required to determine effectiveness convincingly. Future studies must include health-related quality of life and symptom-based outcome measures.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

McMurray 2008 {published and unpublished data}
    1. McMurray JS, Connor N, Ford CF. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double‐blind, placebo‐controlled study. Annals of Otology, Rhinology & Laryngology 2008;117(7):477‐83. - PubMed

References to studies excluded from this review

Morrison 2003 {published data only (unpublished sought but not used)}
    1. Morrison GA. Adjunctive treatment for recurrent respiratory papillomatosis using topical cidofovir. National Research Register. [N0013101019]
Ostrow 1999 {published data only (unpublished sought but not used)}
    1. Ostrow R. Adjunct therapy presentations and discussions from the International Papillomavirus Conference ‐ 1999. 17th Annual International Papillomavirus Conference, Charleston, USA. 1999.

Additional references

BNF 2003
    1. Mehta DK. British National Formulary. 6th Edition. British Medical Association and Royal Pharmaceutical Society of Great Britain, 2003.
Campisi 2009
    1. Campisi P. Personal communication September 2009.
Corbitt 1988
    1. Corbitt G, Zarod AP, Arrand JR, Longson M, Farrington WT. Human papillomavirus (HPV) genotypes associated with laryngeal papilloma. Journal of Clinical Pathology 1988;41(3):284‐8. [PUBMED: 2834419] - PMC - PubMed
Derkay 1995
    1. Derkay CS. Task force on recurrent respiratory papillomas. A preliminary report. Archives of Otolaryngology ‐ Head and Neck Surgery 1995;121(12):1386‐91. - PubMed
Derkay 1998
    1. Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 1998;108(6):935‐7. [PUBMED: 9628513] - PubMed
Derkay 2001
    1. Derkay CS. Recurrent respiratory papillomatosis. Laryngoscope 2001;111:57‐69. - PubMed
Dillner 1999
    1. Dillner J, Andersson‐Ellstrom A, Hagmar B, Schiller J. High risk genital papillomavirus infections are not spread vertically. Reviews in Medical Virology 1999;9(1):23‐9. [PUBMED: 10371669] - PubMed
Gissman 1982
    1. Gissmann L, Diehl V, Schultz‐Coulon HJ, zur Hausen H. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. Journal of Virology 1982;44(1):393‐400. [PUBMED: 6292500] - PMC - PubMed
Handbook 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hester 2003
    1. Hester RP, Derkay CS, Burke BL, Lawson ML. Reliability of a staging assessment system for recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology 2003;67(5):505‐9. [PUBMED: 12697352] - PubMed
Kashima 1992
    1. Kashima HK, Shah F, Lyles A, Glackin R, Muhammad N, Turner L, et al. A comparison of risk factors in juvenile‐onset and adult‐onset recurrent respiratory papillomatosis. Laryngoscope 1992;102(1):9‐13. [PUBMED: 1309932] - PubMed
Kimberlin 2004
    1. Kimberlin DW. Current status of antiviral therapy for juvenile‐onset recurrent respiratory papillomatosis. Antiviral Research 2004;63(3):141‐51. - PubMed
Menzo 2001
    1. Menzo S, Monachetti A, Trozzi C, Ciavattini A, Carloni G, Varaldo PE, et al. Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. Journal of Virology 2001;75(23):11913‐9. - PMC - PubMed
Pou 1995
    1. Pou AM, Rimell FL, Jordan JA, Shoemaker DL, Johnson JT, Barua P, et al. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Annals of Otology, Rhinology and Laryngology 1995;104(10 Pt 1):758‐62. [PUBMED: 7574251] - PubMed
Rabah 2001
    1. Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus‐11‐associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus‐6‐associated disease. Pediatric and Developmental Pathology 2001;4(1):68‐72. [PUBMED: 11200493] - PubMed
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Schraff 2004
    1. Schraff S, Derkay CS, Burke B, Lawson L. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Archives of Otolaryngology ‐ Head and Neck Surgery 2004;130(9):1039‐42. - PubMed
Shykhon 2002
    1. Shykhon M, Kuo M, Pearman K. Recurrent respiratory papillomatosis. Clinical Otolaryngology and Allied Sciences 2002;27:237‐43. - PubMed
Silverberg 2003
    1. Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV. Condyloma in pregnancy is strongly predictive of juvenile‐onset recurrent respiratory papillomatosis. Obstetrics and Gynecology 2003;101(4):645‐52. [PUBMED: 12681865] - PubMed
Tasca 2006
    1. Tasca RA, McCormick M, Clarke RW. British Association of Paediatric Otorhinolaryngology members experience with recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology 2006;70:1183‐7. - PubMed
Varni 1999
    1. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Medical Care 1999;37(2):126‐39. - PubMed
Ware 1996
    1. Ware J Jr, Kosinski M, Keller SD. A 12‐Item Short‐Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care 1996;34(3):220‐33. - PubMed
Zur 2007
    1. Zur KB, Cotton S, Kelchner L, Baker S, Weinrich B, Lee L. Pediatric Voice Handicap Index (pVHI): a new tool for evaluating pediatric dysphonia. International Journal of Pediatric Otorhinolaryngology 2007;71:77‐82. - PubMed

References to other published versions of this review

Chadha 2005
    1. Chadha NK, James AL. Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD005053.pub2] - DOI - PubMed
Chadha 2010
    1. Chadha NK, James A. Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD005053.pub3] - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources